[1]
Ghezzi, L., Exeni, A., Velasco, J., Barrionuevo, T., Coccia, P., Ferraris, V., Freyle Fraija, L., Cisnero, D. and Rigali, M.P. 2020. Use of Eculizumab in Typical Hemolytic Uremic Syndrome. A therapeutic option in severe neurological compromise. Two case reports. Revista de Nefrología, Diálisis y Trasplante. 40, 1 (Aug. 2020), 39-45.